Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 101

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 101
---
 office of the Company,
for a new Note or Notes (in accordance with Section (3)(d)) representing in the aggregate the outstanding Principal of this Note, and
each such new Note will represent such portion of such outstanding Principal as is designated by the Holder at the time of such surrender.

(d) .
Whenever the Company is required to issue a new Note pursuant to the terms hereof, such new Note (i) shall be of like tenor with this
Note, (ii) shall represent, as indicated on the face of such new Note, the Principal remaining outstanding, (iii) shall have an issuance
date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall have the same rights
and conditions as this Note, and (v) shall represent accrued and unpaid Interest from the Issuance Date.

(4) . Any notices, consents, waivers
or other communications required or permitted to be given under the terms hereof must be in writing by letter and email and will be deemed
to have been delivered: upon the later of (A) either (i) receipt, when delivered personally or (ii) one (1) Business Day after deposit
with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same
and (B) receipt, when sent by electronic mail. The addresses and e-mail addresses for such communications shall be:

| If to the Company, to: | Biodexa Pharmaceuticals PLC             
 1 Caspian Point                         
 Caspian Way                             
 Cardiff, CF10 4DQ                       
 United Kingdom                          
 Attention: Stephen Stamp                
 E-mail: Stephen.stamp@biodexapharma.com |

| with a copy (which shall not 
 constitute notice) to:       | Mintz, Levin, Cohn, Ferris, Glovsky               
 and Popeo, P.C.                                   
 One Financial Center                              
 Boston, Massachusetts 02111                       
 Attention: Jason S. McCaffrey                     
 Email: JSMcCaffrey@mintz.com                      |
| If to the Holder:            | C/M Capital Master Fund, LP                       
 1111 Brickell Avenue                              
 Suite 2920                                        
 Miami, Florida 33131                              
 Attention: Thomas Walsh/Jonathan Juchno           
 E-mail: thomas@cm-funds.com/jonathan@cm-funds.com |
| with a copy (which shall not 
 constitute